放射诱导球膜部尿道狭窄重建中吻合式尿道成形术较颊黏膜补片术狭窄复发风险更低
中位狭窄长度2.0 cm,中位随访97个月。Cox回归显示颊黏膜补片术与狭窄复发独立相关(HR 3.43,95% CI 1.03-11.47;P = .046)。在技术可行时,吻合式尿道成形术与更低的狭窄复发风险相关,且不增加不良事件风险。
要点
- 颊黏膜补片术较吻合式尿道成形术狭窄复发风险更高(HR 3.43,P = .046)。
- 补片术1、2、10年累积复发风险17%、18%、20%,吻合术为3.3%、5.0%、6.8%。
- 两种技术在并发症、满意度、新发勃起功能障碍及尿失禁方面无显著差异。
核心结论
- 在技术可行时,吻合式尿道成形术较颊黏膜补片术治疗放疗后球膜部尿道狭窄的狭窄复发风险更低,且不增加不良事件风险。
主要发现
- 中位狭窄长度2.0 cm(IQR 2.0-3.0),无复发患者中位随访97个月(IQR 52-144)。
- 病因包括近距离放疗46%、外照射放疗45%、联合治疗9.0%。
- Cox回归显示颊黏膜补片术与狭窄复发独立相关(HR 3.43,95% CI 1.03-11.47;P = .046),而年龄(P = .3)、狭窄长度(P = .1)、糖尿病(P = .7)、吸烟(P = .5)、肥胖(P = .6)及既往内镜治疗(P = .6)均不相关。
- 颊黏膜补片术1、2、10年累积狭窄复发风险分别为17%、18%、20%,吻合式尿道成形术分别为3.3%、5.0%、6.8%(log-rank P = .01)。
- 两组并发症(10% vs 4.1%;P = .3)、满意度(90% vs 88%;P = .6)、新发勃起功能障碍(15% vs 8.2%;P = .2)及尿失禁(18% vs 18%;P = 1.0)均无显著差异。
临床怎么用
- 对于放疗后球膜部尿道狭窄,在技术可行时优先考虑吻合式尿道成形术以降低狭窄复发风险。
- 颊黏膜补片术仍可用于吻合不可行的病例,但需告知患者狭窄复发风险较高。
局限性
- 回顾性研究设计,仅纳入2个中心,颊黏膜补片术样本量较小(49例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The preferred treatment of bulbomembranous urethral stenosis (BMUS) after prostate cancer radiotherapy remains unclear. The purpose of this study was to examine the association of surgical technique and outcomes after urethroplasty for radiation-induced BMUS. MATERIALS AND METHODS: From January 2001 to September 2024, a review of patients undergoing posterior urethroplasty for BMUS at 2 centers was performed. The primary outcome was stricture recurrence defined as stricture < 16Fr confirmed on cystoscopy. Secondary outcomes included 90-day complications (Clavien ≥ 2), patient-reported satisfaction, de novo erectile dysfunction, or incontinence. Cox regression was used to evaluate variables associated with stricture recurrence, and Fisher exact test was used for secondary outcomes. RESULTS: Two hundred twelve patients with radiation-induced BMUS were reconstructed with either anastomotic urethroplasty (163) or buccal mucosal graft (BMG) (49). Median stenosis length was 2.0 cm (IQR 2.0-3.0); median follow-up for patients without recurrence was 97 months (IQR 52-144); and etiology was brachytherapy (46%), external beam radiotherapy (45%), or combination (9.0%). On Cox regression, BMG urethroplasty was independently associated with stricture recurrence (HR 3.43, 95% CI 1.03-11.47; P = .046), whereas patient age (P = .3), stenosis length (P = .1), diabetes (P = .7), smoking (P = .5), obesity (P = .6), and prior endoscopic treatments (P = .6) were not. For BMG urethroplasty, the estimated cumulative risk of stricture recurrence at 1, 2, and 10 years was 17%, 18%, and 20% compared with 3.3%, 5.0%, and 6.8%, respectively, for anastomotic urethroplasty (log-rank P = .01). Techniques did not differ in complications (10% vs 4.1%; P = .3), satisfaction (90% vs 88%; P = .6), erectile dysfunction (15% vs 8.2%; P = .2), or incontinence (18% vs 18%; P = 1.0). CONCLUSIONS: When technically feasible, anastomotic urethroplasty is associated with a lower risk of stricture recurrence compared with onlay with buccal mucosa when reconstructing radiation-induced bulbomembranous urethral stenosis without a higher risk of adverse events.
引用
- Rourke K, Gelman J. Anastomotic Urethroplasty is Associated with a Lower Risk of Stricture Recurrence Compared with Buccal Mucosa Graft Onlay After Reconstruction for Radiation-Induced Bulbomembranous Urethral Stenosis. J Urol. 2026. PMID: 42647825. doi:10.1097/JU.0000000000005279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。